Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China flag China · Delayed Price · Currency is CNY
28.08
-0.75 (-2.60%)
Apr 9, 2026, 4:00 PM EDT

SHE:301089 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
140.2669.23148.55307.09284.22
Trading Asset Securities
105.15250.88190.7240.16220.62
Cash & Short-Term Investments
245.41320.11339.26547.25504.84
Cash Growth
-23.34%-5.64%-38.01%8.40%219.08%
Accounts Receivable
126.12151.52235.3205.41103.58
Other Receivables
0.0621.3212.5713.660.62
Receivables
126.18172.84247.87219.07104.2
Inventory
181.61178.88204.11241.14167.08
Other Current Assets
31.755.1830.936.5420.64
Total Current Assets
584.95677.01822.171,014796.76
Property, Plant & Equipment
862.77874.54809.38610.26449.11
Long-Term Investments
19.77.958.3710.8612.54
Other Intangible Assets
80.1281.8384.0484.2684.56
Long-Term Accounts Receivable
-0.26---
Long-Term Deferred Tax Assets
70.9869.5863.7170.366.51
Long-Term Deferred Charges
3.6242.71.862.33
Other Long-Term Assets
43.1643.0848.6251.6441.9
Total Assets
1,6651,7581,8391,8431,394
Accounts Payable
118.01133.21152.55158.58162.94
Accrued Expenses
10.1922.8124.5869.0917.51
Short-Term Debt
---40.0364.5
Current Portion of Long-Term Debt
1.01----
Current Portion of Leases
-0.97--4.91
Current Income Taxes Payable
3.19-066.051.31
Current Unearned Revenue
1.690.915.4871.892.9
Other Current Liabilities
11.867.4311.918.320.53
Total Current Liabilities
145.97165.32194.51423.96254.6
Long-Term Leases
2.243.25---
Long-Term Unearned Revenue
30.5532.9435.1738.3140.4
Long-Term Deferred Tax Liabilities
2.364.216.044.611.36
Total Liabilities
181.12205.72235.72466.89296.35
Common Stock
126.54126.54126.54126126
Additional Paid-In Capital
621.11621.11621.11585.3578.54
Retained Earnings
732.99802.66854.18661.5387.57
Comprehensive Income & Other
3.532.211.443.575.25
Total Common Equity
1,4841,5531,6031,3761,097
Shareholders' Equity
1,4841,5531,6031,3761,097
Total Liabilities & Equity
1,6651,7581,8391,8431,394
Total Debt
3.254.22-40.0369.41
Net Cash (Debt)
242.16315.89339.26507.22435.43
Net Cash Growth
-23.34%-6.89%-33.11%16.49%-
Net Cash Per Share
1.912.542.694.024.37
Filing Date Shares Outstanding
129.61126.54126.54126126
Total Common Shares Outstanding
129.61126.54126.54126126
Working Capital
438.98511.69627.66590.04542.16
Book Value Per Share
11.4512.2712.6710.928.71
Tangible Book Value
1,4041,4711,5191,2921,013
Tangible Book Value Per Share
10.8311.6212.0110.258.04
Buildings
-283.94267.66257.26210.62
Machinery
-420.02382.3354.84301.65
Construction In Progress
-372.68331.03130.4835.59
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.